老年卒中患者卵圆孔未闭封堵术：DEFENSE-PFO试验的亚组分析 - Suppr

Suppr

超能文献

Patent Foramen Ovale Closure in Old Stroke Patients: A Subgroup Analysis of the DEFENSE-PFO Trial.

作者信息

Kwon Hanim, Lee Pil Hyung, Song Jae-Kwan, Kwon Sun U, Kang Dong-Wha, Kim Jong S

机构信息

Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

J Stroke. 2021 May;23(2):289-292. doi: 10.5853/jos.2021.00647. Epub 2021 May 31.

DOI:10.5853/jos.2021.00647

PMID:34102766

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8189858/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/006e/8189858/641a00e5aff5/jos-2021-00647f1.jpg

相似文献

Patent Foramen Ovale Closure in Old Stroke Patients: A Subgroup Analysis of the DEFENSE-PFO Trial.

J Stroke. 2021 May;23(2):289-292. doi: 10.5853/jos.2021.00647. Epub 2021 May 31.

Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.

J Am Coll Cardiol. 2018 May 22;71(20):2335-2342. doi: 10.1016/j.jacc.2018.02.046. Epub 2018 Mar 12.

Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.

JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.

Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.

Catheter Cardiovasc Interv. 2018 Jul;92(1):165-173. doi: 10.1002/ccd.27615. Epub 2018 Mar 30.

Recurrent Stroke Reduction with Patent Foramen Ovale Closure versus Medical Therapy Based on Patent Foramen Ovale Characteristics: A Meta-Analysis of Randomized Controlled Trials.

Cardiology. 2019;144(1-2):40-49. doi: 10.1159/000500501. Epub 2019 Oct 1.

Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.

Cerebrovasc Dis. 2018;45(3-4):162-169. doi: 10.1159/000487959. Epub 2018 Mar 29.

Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale.

J Am Coll Cardiol. 2020 May 12;75(18):2312-2320. doi: 10.1016/j.jacc.2020.02.068.

The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.

Circ Cardiovasc Interv. 2018 Mar;11(3):e004152. doi: 10.1161/CIRCINTERVENTIONS.117.004152.

Patent foramen ovale closure versus medical therapy for stroke prevention: A systematic review and meta-analysis of randomized controlled trials.

F1000Res. 2017 Dec 27;6:2178. doi: 10.12688/f1000research.13444.2. eCollection 2017.

Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial.

Eur Heart J. 2016 Jul 7;37(26):2029-36. doi: 10.1093/eurheartj/ehw027. Epub 2016 Feb 22.

引用本文的文献

Patent Foramen Ovale Closure in Older Patients With Cryptogenic Stroke: Current Evidence and Next Steps.

Struct Heart. 2025 Jul 9;9(8):100699. doi: 10.1016/j.shj.2025.100699. eCollection 2025 Aug.

Assessment of patent foramen ovale closure in elderly patients with cryptogenic transient ischemic attack or stroke: Efficacy, safety, and potential age-related benefit.

Eur Stroke J. 2025 Jun 3:23969873251341764. doi: 10.1177/23969873251341764.

Occlusion of functional high-volume intra-atrial shunts in older patients after embolic stroke of undetermined source.

Front Cardiovasc Med. 2024 Sep 27;11:1402137. doi: 10.3389/fcvm.2024.1402137. eCollection 2024.

Patent Foramen Ovale and Other Cardiopathies as Causes of Embolic Stroke With Unknown Source.

J Stroke. 2024 Sep;26(3):349-359. doi: 10.5853/jos.2024.02670. Epub 2024 Sep 30.

The patent foramen ovale does not spontaneously close in patients aged 60.

EuroIntervention. 2024 Aug 19;20(16):966-7. doi: 10.4244/EIJ-E-24-00040.

Determinants of adverse outcomes following patent foramen ovale closure in elderly patients.

EuroIntervention. 2024 Aug 19;20(16):1029-1038. doi: 10.4244/EIJ-D-24-00156.

Patent Foramen Ovale Closure in Special Clinical Situations: More Questions Than Answers?

Life (Basel). 2024 May 30;14(6):706. doi: 10.3390/life14060706.

Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale.

J Stroke. 2024 May;26(2):242-251. doi: 10.5853/jos.2023.03265. Epub 2024 May 30.

European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke.

Eur Stroke J. 2024 Dec;9(4):800-834. doi: 10.1177/23969873241247978. Epub 2024 May 16.

Heart-Stroke Team: A multidisciplinary assessment of patent foramen ovale-associated stroke.

Eur Stroke J. 2024 Mar;9(1):219-225. doi: 10.1177/23969873231214862. Epub 2023 Nov 18.

本文引用的文献

Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials: A Population-Based Study and Systematic Review.

JAMA Neurol. 2020 Oct 1;77(10):1279-1287. doi: 10.1001/jamaneurol.2020.1948.

Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology.

Neurology. 2020 May 19;94(20):876-885. doi: 10.1212/WNL.0000000000009443. Epub 2020 Apr 29.

Patent Foramen Ovale: Story Closed?

J Stroke. 2019 Jan;21(1):23-30. doi: 10.5853/jos.2018.03097. Epub 2019 Jan 31.

Cardiovascular Risk Factors Associated With Venous Thromboembolism.

JAMA Cardiol. 2019 Feb 1;4(2):163-173. doi: 10.1001/jamacardio.2018.4537.

Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.

J Am Coll Cardiol. 2018 May 22;71(20):2335-2342. doi: 10.1016/j.jacc.2018.02.046. Epub 2018 Mar 12.

Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.

N Engl J Med. 2017 Sep 14;377(11):1011-1021. doi: 10.1056/NEJMoa1705915.

Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.

N Engl J Med. 2017 Sep 14;377(11):1022-1032. doi: 10.1056/NEJMoa1610057.

Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.

N Engl J Med. 2017 Sep 14;377(11):1033-1042. doi: 10.1056/NEJMoa1707404.

Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.

Stroke. 2004 Sep;35(9):2145-9. doi: 10.1161/01.STR.0000135773.24116.18. Epub 2004 Jul 1.

Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects.

Circulation. 2001 Dec 4;104(23):2797-802. doi: 10.1161/hc4801.100076.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验